DE69922681D1 - Kristallisation von doxorubicin-hydrochlorid - Google Patents

Kristallisation von doxorubicin-hydrochlorid

Info

Publication number
DE69922681D1
DE69922681D1 DE69922681T DE69922681T DE69922681D1 DE 69922681 D1 DE69922681 D1 DE 69922681D1 DE 69922681 T DE69922681 T DE 69922681T DE 69922681 T DE69922681 T DE 69922681T DE 69922681 D1 DE69922681 D1 DE 69922681D1
Authority
DE
Germany
Prior art keywords
doxorubicin hydrochloride
crystallization
doxorubicin
carrying
condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69922681T
Other languages
English (en)
Other versions
DE69922681T2 (de
Inventor
Osamu Johdo
Takuma Nakao
Takeo Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mercian Corp
Original Assignee
Mercian Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mercian Corp filed Critical Mercian Corp
Publication of DE69922681D1 publication Critical patent/DE69922681D1/de
Application granted granted Critical
Publication of DE69922681T2 publication Critical patent/DE69922681T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69922681T 1998-10-16 1999-10-15 Kristallisation von doxorubicin-hydrochlorid Expired - Lifetime DE69922681T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30954298 1998-10-16
JP30954298 1998-10-16
PCT/JP1999/005699 WO2000023453A1 (fr) 1998-10-16 1999-10-15 Cristallisation de chlorhydrate de doxorubicine

Publications (2)

Publication Number Publication Date
DE69922681D1 true DE69922681D1 (de) 2005-01-20
DE69922681T2 DE69922681T2 (de) 2005-05-25

Family

ID=17994281

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69922681T Expired - Lifetime DE69922681T2 (de) 1998-10-16 1999-10-15 Kristallisation von doxorubicin-hydrochlorid

Country Status (11)

Country Link
US (1) US6653455B1 (de)
EP (1) EP1122260B1 (de)
JP (1) JP4533537B2 (de)
CN (1) CN1188424C (de)
AT (1) ATE284893T1 (de)
AU (1) AU750738B2 (de)
CA (1) CA2347515C (de)
DE (1) DE69922681T2 (de)
ES (1) ES2235518T3 (de)
NZ (1) NZ511093A (de)
WO (1) WO2000023453A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
CN101331147B (zh) * 2005-12-13 2011-11-30 苏洛克股份有限公司 用于制备4-脱甲基柔红霉素的方法
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
WO2007085615A1 (en) * 2006-01-24 2007-08-02 Biocompatibles Uk Limited Process for loading polymer particles with drug
US7470672B2 (en) 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
US7750018B2 (en) * 2006-12-06 2010-07-06 Tactical Therapeutics, Inc Use of carboxiamidotriazole (CAI) orotate in macular degeneration
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
EA201100851A1 (ru) 2008-12-23 2012-04-30 Фармассет, Инк. Аналоги нуклеозидов
NZ593648A (en) 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
EP2636676A3 (de) * 2009-09-08 2014-01-01 Heraeus Precious Metals GmbH & Co. KG Kristallisierung von Epidaunorubicin x HCI
BR112012024884A2 (pt) 2010-03-31 2016-10-18 Gilead Pharmasset Llc síntese estereosseletiva de ativos contendo fósforo
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
EP2609923B1 (de) 2010-03-31 2017-05-24 Gilead Pharmasset LLC Verfahren zur krystallisierung von (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoat
AR084044A1 (es) 2010-11-30 2013-04-17 Pharmasset Inc Compuestos 2’-espiro-nucleosidos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US3803124A (en) * 1968-04-12 1974-04-09 Farmaceutici It Soc Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
IT1155446B (it) 1982-12-23 1987-01-28 Erba Farmitalia Procedimento per la purificazione di glucosidi antraciclinonici mediante adsobimento selettivo su resine
HU204570B (en) 1989-09-04 1992-01-28 Gyogyszerkutato Intezet Process for purifying adriamycin-hydrochloride
JP3980101B2 (ja) * 1996-11-25 2007-09-26 財団法人微生物化学研究会 結晶質アントラサイクリン抗生物質およびその製造方法
JP2975018B2 (ja) * 1997-11-28 1999-11-10 住友製薬株式会社 結晶性塩酸アムルビシン

Also Published As

Publication number Publication date
ES2235518T3 (es) 2005-07-01
CA2347515A1 (en) 2000-04-27
US6653455B1 (en) 2003-11-25
CN1323312A (zh) 2001-11-21
NZ511093A (en) 2003-04-29
AU6123499A (en) 2000-05-08
ATE284893T1 (de) 2005-01-15
WO2000023453A1 (fr) 2000-04-27
EP1122260B1 (de) 2004-12-15
CA2347515C (en) 2009-10-13
EP1122260A1 (de) 2001-08-08
EP1122260A4 (de) 2001-12-19
DE69922681T2 (de) 2005-05-25
CN1188424C (zh) 2005-02-09
JP4533537B2 (ja) 2010-09-01
AU750738B2 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
DE69922681D1 (de) Kristallisation von doxorubicin-hydrochlorid
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
ES2181853T3 (es) Tratamiento del tinnitus empleando agentes neuroprotectores.
FR2777562B1 (fr) Procede de purification d'aminonitriles aliphatiques
IT1313618B1 (it) Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici eprocedimento per la loro preparazione.
MA25654A1 (fr) Cristallisation selective du sel de sodium de l'acide 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonique, sous la forme hemipentahydrate au monohydrate.
HUP0203075A3 (en) Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
IT1299705B1 (it) Struttura di elemento di guida e rinvio, particolarmente per lacci.
MA25223A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
WO2000023407A3 (en) Ureido-thiobutyric acid derivatives as ppar-agonists
FR2708601B1 (fr) Procédé de cristallisation d'Iopamidol.
TR28873A (tr) N-sübstitüe edilmis, N,N'-kaynasik heterosiklik benzoik asit üretmeye mahsus yöntem.
ITBO980312A0 (it) Metodo per confezionare articoli all'interno di relativi astucci.
NO20014077L (no) Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid
DZ2770A1 (fr) Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
BR0013094B1 (pt) processo para a preparação de compostos 1,3-dicarbonìlicos acilados.
IT241651Y1 (it) Macchina perfezionata per la produzione di granita.
FR2780967B1 (fr) Procede de preparation de derives du 2,3-dihydrobenzofurane -2,2-disubstitues
MXPA01013317A (es) Maquina para cristalizacion.
FR2794031B1 (fr) Procede de cristallisation d'une solution aqueuse
FR2795847B1 (fr) Procede de perfectionnement de fabrication d'un insert
FR2780617B1 (fr) Procede de fabrication d'une preparation laitiere concentree sucree et produit obtenu
DE59707886D1 (de) 1,3,5-trifluornaphthalin-derivate für flüssigkristallinen mischungen
FR2808274B1 (fr) Procede de preparation des n, n'-carbonylbislactames
EP1052244A4 (de) Verfahren zur herstellung von 4,6-diaminoresorcinol oder salzen davon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition